Trial Profile
Phase IIa study of bertilimumab in patients with severe atopic dermatitis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2016
Price :
$35
*
At a glance
- Drugs Bertilimumab (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 17 Nov 2016 According to an Immune Pharmaceuticals Inc media release, this trial is expected to initiate in 2017.
- 25 May 2016 New trial record